JP2025515314A - 緩衝剤を含有する組成物及びその使用方法 - Google Patents

緩衝剤を含有する組成物及びその使用方法 Download PDF

Info

Publication number
JP2025515314A
JP2025515314A JP2024563042A JP2024563042A JP2025515314A JP 2025515314 A JP2025515314 A JP 2025515314A JP 2024563042 A JP2024563042 A JP 2024563042A JP 2024563042 A JP2024563042 A JP 2024563042A JP 2025515314 A JP2025515314 A JP 2025515314A
Authority
JP
Japan
Prior art keywords
composition
μmol
compound
mosm
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024563042A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515314A5 (enExample
Inventor
ドリュー スティーブン フォーク，
ネイサン アラン スタスコ，
レベッカ アントゥアールド マクドナルド，
ジョン ケリー シモンズ，
ウィリアム リロイ ザ セカンド ロバーツ，
Original Assignee
ノウ バイオ， エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノウ バイオ， エルエルシー filed Critical ノウ バイオ， エルエルシー
Publication of JP2025515314A publication Critical patent/JP2025515314A/ja
Publication of JP2025515314A5 publication Critical patent/JP2025515314A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
JP2024563042A 2022-04-28 2023-04-25 緩衝剤を含有する組成物及びその使用方法 Pending JP2025515314A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263335822P 2022-04-28 2022-04-28
US63/335,822 2022-04-28
PCT/US2023/019807 WO2023211932A1 (en) 2022-04-28 2023-04-25 Buffering agent-containing compositions and methods of using same

Publications (2)

Publication Number Publication Date
JP2025515314A true JP2025515314A (ja) 2025-05-14
JP2025515314A5 JP2025515314A5 (enExample) 2026-05-11

Family

ID=86469370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024563042A Pending JP2025515314A (ja) 2022-04-28 2023-04-25 緩衝剤を含有する組成物及びその使用方法

Country Status (7)

Country Link
US (1) US20250281512A1 (enExample)
EP (1) EP4514319A1 (enExample)
JP (1) JP2025515314A (enExample)
CN (1) CN119136783A (enExample)
AU (1) AU2023260344A1 (enExample)
CA (1) CA3250927A1 (enExample)
WO (1) WO2023211932A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250339449A1 (en) * 2024-05-02 2025-11-06 Know Bio, Llc Inhalation formulations containing nitric oxide releasing compounds and methods of using same
CN119523952B (zh) * 2024-10-17 2026-03-10 河北医科大学 一种多黏菌素吸入液体制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
US20120076859A1 (en) * 2010-09-23 2012-03-29 Activaero Gmbh Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary Diseases
CA3280124A1 (en) * 2013-07-31 2025-10-31 Avalyn Pharma Inc. Aerosol imatinib compounds and uses thereof
EP4548975A3 (en) * 2015-09-09 2025-07-23 Beyond Air Ltd Nitric oxide inhalation therapy for infants with bronchiolitis
US12390479B2 (en) * 2020-02-07 2025-08-19 Know Bio, Llc Nitric oxide-releasing antibacterial compounds, formulations, and methods pertaining thereto
WO2022051606A1 (en) * 2020-09-04 2022-03-10 Know Bio, Llc Nitric oxide donors, compositions, and methods of use

Also Published As

Publication number Publication date
CN119136783A (zh) 2024-12-13
CA3250927A1 (en) 2023-11-02
WO2023211932A1 (en) 2023-11-02
AU2023260344A1 (en) 2024-11-07
US20250281512A1 (en) 2025-09-11
EP4514319A1 (en) 2025-03-05

Similar Documents

Publication Publication Date Title
US20230372362A1 (en) Methods for treating lung infections and inflammation
US20100196516A1 (en) Treatment of infections by carbon monoxide
US20250281512A1 (en) Buffering agent-containing compositions and methods of using same
RU2018115685A (ru) Фармацевтическая композиция
EP3360547B1 (en) Bactericidal pharmaceutical composition comprising ibuprofen
CN106573944A (zh) 作为抗菌剂的金(i)‑膦化合物
EP3592430B1 (en) Antimicrobial compounds, compositions, and uses thereof
US20220152063A1 (en) Nitric oxide-releasing antibacterial compounds, formulations, and methods pertaining thereto
CN106459116A (zh) 作为抗菌剂的金(i)‑膦化合物
JP2025519511A (ja) 一酸化窒素放出化合物を含む多成分医薬組成物及びキット、並びにその使用方法
EP3236949B1 (en) Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof
US20250339449A1 (en) Inhalation formulations containing nitric oxide releasing compounds and methods of using same
US11529312B2 (en) Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use
EP3866775B1 (en) Cysteamine for use in the treatment of lung diseases
JP2024547022A5 (enExample)
HK40018480B (en) Antimicrobial compounds, compositions, and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260423

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260423